Marco Valvano

457 total citations
23 papers, 300 citations indexed

About

Marco Valvano is a scholar working on Surgery, Epidemiology and Genetics. According to data from OpenAlex, Marco Valvano has authored 23 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 11 papers in Epidemiology and 11 papers in Genetics. Recurrent topics in Marco Valvano's work include Inflammatory Bowel Disease (11 papers), Microscopic Colitis (11 papers) and Eosinophilic Esophagitis (3 papers). Marco Valvano is often cited by papers focused on Inflammatory Bowel Disease (11 papers), Microscopic Colitis (11 papers) and Eosinophilic Esophagitis (3 papers). Marco Valvano collaborates with scholars based in Italy, United States and Lebanon. Marco Valvano's co-authors include Giovanni Latella, Angelo Viscido, Filippo Vernia, Salvatore Longo, Gianpiero Stefanelli, S. Fabiani, Giuseppe Frieri, Antonio Vinci, Chiara Castellini and A Ciccone and has published in prestigious journals such as International Journal of Molecular Sciences, Nutrients and Inflammatory Bowel Diseases.

In The Last Decade

Marco Valvano

20 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Valvano Italy 9 119 118 75 65 57 23 300
Heba Iskandar United States 8 158 1.3× 208 1.8× 21 0.3× 101 1.6× 90 1.6× 20 399
Moritz Meyer Austria 6 67 0.6× 89 0.8× 13 0.2× 68 1.0× 20 0.4× 8 426
Ruth Thieroff‐Ekerdt United States 11 54 0.5× 26 0.2× 36 0.5× 109 1.7× 32 0.6× 19 372
Dina Patel United Kingdom 11 206 1.7× 40 0.3× 22 0.3× 172 2.6× 244 4.3× 26 601
Sayantan Ray India 12 62 0.5× 25 0.2× 40 0.5× 61 0.9× 11 0.2× 39 366
Efthymios P. Tsounis Greece 9 83 0.7× 51 0.4× 29 0.4× 30 0.5× 10 0.2× 22 245
Karina González-Aldaco Mexico 12 162 1.4× 52 0.4× 24 0.3× 43 0.7× 5 0.1× 21 305
Arzu Tiftikçi Türkiye 10 93 0.8× 61 0.5× 17 0.2× 159 2.4× 66 1.2× 25 344
Giuseppe Baviera Italy 5 359 3.0× 45 0.4× 28 0.4× 75 1.2× 28 0.5× 5 593
Lingjie Fu China 9 57 0.5× 34 0.3× 75 1.0× 37 0.6× 7 0.1× 11 372

Countries citing papers authored by Marco Valvano

Since Specialization
Citations

This map shows the geographic impact of Marco Valvano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Valvano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Valvano more than expected).

Fields of papers citing papers by Marco Valvano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Valvano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Valvano. The network helps show where Marco Valvano may publish in the future.

Co-authorship network of co-authors of Marco Valvano

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Valvano. A scholar is included among the top collaborators of Marco Valvano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Valvano. Marco Valvano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ingravalle, Fabio, Marco Valvano, Andréa Barbará, et al.. (2025). Inflammatory Bowel Disease in the Post-STRIDE II Era: Epidemiology and Long-Term Clinical Outcomes from a Population-Based Study. Medical Sciences. 13(2). 55–55. 1 indexed citations
2.
Capasso, Mario, et al.. (2025). Pancreatic Enzyme Replacement Therapy: Not Only in Chronic Pancreatitis. Journal of Gastrointestinal and Liver Diseases. 34(3). 390–399.
3.
Stefanelli, Gianpiero, Marco Valvano, Stefano Necozione, et al.. (2025). Inter-rater Reliability and Accuracy of NBI Score for Activity Evaluation in Ulcerative Colitis. Reviews on Recent Clinical Trials. 20.
4.
Valvano, Marco, Daniele Balducci, Antonio Vinci, et al.. (2025). Biliary stent insertion after stone clearance in patients awaiting cholecystectomy: Systematic review and meta-analysis. Endoscopy International Open. 13(CP). a25866007–a25866007.
6.
Valvano, Marco, Gianpiero Stefanelli, S. Fabiani, et al.. (2024). The role of new inflammatory indices in the prediction of endoscopic and histological activity in inflammatory bowel disease patients. European Journal of Gastroenterology & Hepatology. 37(1). 24–32. 3 indexed citations
7.
Valvano, Marco, et al.. (2023). Nutrition, Nutritional Status, Micronutrients Deficiency, and Disease Course of Inflammatory Bowel Disease. Nutrients. 15(17). 3824–3824. 18 indexed citations
8.
Valvano, Marco, S. Fabiani, Salvatore Longo, et al.. (2023). The connection between diverticulosis and colonic superficial neoplastic lesions in patients who underwent screening colonoscopy. International Journal of Colorectal Disease. 38(1). 107–107. 3 indexed citations
9.
Frieri, Giuseppe, et al.. (2023). Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn’s Patients. Journal of Clinical Medicine. 12(9). 3130–3130. 5 indexed citations
10.
Valvano, Marco, et al.. (2023). Old and New Adjunctive Therapies in Celiac Disease and Refractory Celiac Disease: A Review. International Journal of Molecular Sciences. 24(16). 12800–12800. 6 indexed citations
11.
Viscido, Angelo, Marco Valvano, Gianpiero Stefanelli, et al.. (2022). Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis. BMC Gastroenterology. 22(1). 92–92. 26 indexed citations
12.
Longo, Salvatore, Emma Altobelli, Chiara Castellini, et al.. (2022). Non-steroidal anti-inflammatory drugs and acetylsalicylic acid increase the risk of complications of diverticular disease: a meta-analysis of case–control and cohort studies. International Journal of Colorectal Disease. 37(3). 521–529. 8 indexed citations
13.
Vernia, Filippo, Stefano Necozione, Marco Valvano, et al.. (2022). Is mastocytic colitis a specific clinical-pathological entity?. European Journal of Histochemistry. 66(4). 1 indexed citations
14.
Vernia, Filippo, et al.. (2022). Vitamin D in Inflammatory Bowel Diseases. Mechanisms of Action and Therapeutic Implications. Nutrients. 14(2). 269–269. 89 indexed citations
15.
Vinci, Antonio, et al.. (2022). Cannabinoid Therapeutic Effects in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Biomedicines. 10(10). 2439–2439. 14 indexed citations
16.
Vernia, Filippo, Marco Valvano, S. Fabiani, et al.. (2021). Are Volatile Organic Compounds Accurate Markers in the Assessment of Colorectal Cancer and Inflammatory Bowel Diseases? A Review. Cancers. 13(10). 2361–2361. 39 indexed citations
17.
Valvano, Marco, Salvatore Longo, Gianpiero Stefanelli, et al.. (2021). The Usefulness of Serum Vitamin D Levels in the Assessment of IBD Activity and Response to Biologics. Nutrients. 13(2). 323–323. 22 indexed citations
18.
Vernia, Filippo, Angelo Viscido, Mirko Di Ruscio, et al.. (2021). Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn’s Disease: Do They Still Have a Potential Clinical Role?. Digestion. 102(6). 833–844. 7 indexed citations
19.
Valvano, Marco, Salvatore Longo, Gianpiero Stefanelli, et al.. (2020). Celiac Disease, Gluten-Free Diet, and Metabolic and Liver Disorders. Nutrients. 12(4). 940–940. 32 indexed citations
20.
Stefanelli, Gianpiero, Angelo Viscido, Marco Valvano, et al.. (2020). Is mesalazine treatment effective in the prevention of diverticulitis? A review.. PubMed. 24(15). 8164–8176. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026